eliminating pediatric hiv/aids and caring for children with hiv
TRANSCRIPT
Dr. Laura GuayVice President of Research
Elizabeth Glaser Pediatric AIDS Foundation
IAS 2011 Media Training & BriefingJuly 16, 2011Rome, Italy
Eliminating Pediatric HIV/AIDS, and Caring for Children with HIV
Elizabeth Glaser
Ariel and Jake Glaser
The Elizabeth Glaser Pediatric AIDS Foundation - 1988
HIV Disease Course
• HIV antibody tests – When exposed to HIV (or any infection) the body
makes antibodies to fight the infection– Standard HIV tests measure these antibodies (EIA,
rapid tests, western blot) – HIV antibodies from an HIV-infected woman cross
the placenta and enter the baby’s blood
• HIV detection tests– These tests measure the actual parts of the HIV
virus itself (PCR, p24 antigen, viral culture)– These tests can identify HIV infection in a very
young baby
Diagnosis of HIV
WHO’s 4-Component Strategy for MTCT Prevention
Prevention of HIV in women,
especially young
women
Prevention of unintended pregnancies
in HIV-infected women
Prevention of transmission from an HIV-
infected woman to her
infant
Support for HIV-infected
women, their infants, and
families
Component
1
Component
2
Component
3
Component
4
Year
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 20070
400 000
500 000
600 000
200 000
300 000
100 000
This bar indicates the range
New Global HIV Infections among Children, 1990–2007
Provision of Antiretroviral Drugs,2004-2009
WHO, UNAIDS, UNICEF - Towards Universal Access: Progress Report 2009
Review of Latest Data - 2009
New Global HIV Infections among Children:
370,000 children were infected with HIV – More than 1,000 children EVERY DAY
Provision of Antiretroviral Drugs:
53 % of pregnant women living with HIV received ARVs - 47% did NOT
35% of infants born to pregnant women living with HIV received ARVs – 65% did NOT
Benefits of Global Expansion of PMTCT Programs• Provides opportunity for primary prevention for
large number of identified HIV-uninfected women
• Provides opportunity for prevention of HIV infection in children
• Provides opportunity for entry point into HIV Care for large number of HIV-infected women and their infected infants― However, this is often a missed opportunity as
ongoing HIV care and treatment is not available
- about 30 out of 100 babies born to these women will get HIV.
If women with HIV do not take any HIV drugs during pregnancy and they breastfeed -
Timing of HIV transmission to the infant
During pregnancy Around labor/delivery During Breastfeeding
If women and newborns take 1 dose of the drug nevirapine around the time the baby is born -
- only ~16 out of 100 babies will getHIV from their mothers.
If women and newborns take a combination of HIV drugs during pregnancy and after delivery -
- as few as 4-6 out of 100 babies will get HIV from their mothers.
United NationsSCN NewsMay 1991
“Use my pictureif it will help,“I don’t wantother people tomake the samemistake”.
Breast Feeding vs Bottle Feeding
2010 Revised WHO Guidelines
Key Changes in 2010 Revised WHO guidelines•Begin ART at CD4 cell count of 350 rather than 200
•Start ARV prophylaxis earlier in pregnancy
•Provide ARV prophylaxis during breastfeeding• Provide single drug Nevirapine daily to infants OR• Provide three drug ARV prophylaxis to the mother
•National authorities should decide whether MCH services will recommend HIV-infected mothers to:• Breastfeed and receive ARV interventions OR• Avoid all breastfeeding
(Taking into account socioeconomics, health services, and local infant mortality and under-nutrition)
Infant HIV diagnosis• Early diagnosis of HIV infection in children born
to HIV-infected women is critical― Allows early identification of children who will
benefit from antiretroviral treatment, appropriate infant feeding choices, prophylaxis, and close medical follow-up
― Decreases the psychological stress of uncertainty for the parents
• HIV detection tests must be used in first 12-18 mos., then standard antibody tests are accurate
• Early infant diagnosis using dried blood spots has made services available even in remote areas
Infant Survival by HIV Infection Status -HIVNET 012 cohort
Proportion
alive
Age (years)
Goals of an HIV Care Program
• Prevention of opportunistic infections
• Early identification of complications and their appropriate management
• Use of antiretroviral therapy to maintain and restore the immune system
• Provision of support for HIV-infected persons, including psychosocial
• Engage patients/families in HIV care and prevention through education, support and outreach
• Establish strong links to community resources
Basic Medical Care
• Close Follow-Up and Health Monitoring- Prompt treatment of acute illnesses
• Childhood Immunization
• Vitamin A Supplementation
• General Health Education (safe water, bednets)
• Management of Diarrhea
• Growth Monitoring & Nutrition Education - Early intervention/support
WHO Indications for Initiation of ARV Therapy in Children < 2 Years• Initial WHO guidelines for ART in infants and
children (2006) recommended starting therapy according to clinical/immunologic criteria
• Studies in infants showed that there was a ~75% decrease in death when ART was started immediately rather than waiting
• WHO revised recommendations in April 2008 such that ALL infants < 1 yr diagnosed with HIV infection should receive ART immediately
• 2010 revised WHO guidelines increased this to all infants < 2 yrs of age
Negotiating PMTCT Activities
?
Negotiating PMTCT Activities (PMTCT = MCH)
The Way Forward: Virtual Elimination of Pediatric HIV and AIDS worldwideChallenges:• High initial implementation costs• Community sensitization/mobilization lacking• Integration of PMTCT within antenatal clinics can be difficult• Access to women who don’t deliver in health facilities• Very low numbers of male partners involved • Inadequate infant feeding education• Poor postnatal follow-up
Successes:• Despite the challenges in scaling up PMTCT services, we
know this can be done, and we have done it• We are making great progress worldwide, but we need to
keep pushing forward to achieve universal access
We can…
eliminate pediatric HIV and AIDS!